Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 362 participants.

Also called NCT02131220

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 362 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02131220
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02131220. Randomized; double masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2017-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Acronym
ERUPTION
Intervention (Drug)
Prourokinase
Intervention (Drug)
Tirofiban
Intervention (Drug)
normal saline
Lead sponsor
Fudan University (class: other)

Record details

Record id
cardio:ct-nct02131220
Content hash
88df6f65c29b5aaea434f41cf74a14b68e8923d445dd1ee58ded83d40683317e